SLDBSolid Biosciences Inc.
- Market cap
- $634.77M
- as of 2026-10-23
- Latest close
- $5.92
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2023-10-05
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Brooks GabrielChief Medical Officer | Oct 19 | Oct 20 | S | 4,374 | $5.62 | Sale −$24,582 | 97,241 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Oct 18 | Oct 20 | M | 9,750 | not reported | not reported | 101,615 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Oct 18 | Oct 20 | M · derivative | 9,750 | $0.00 | $0 | 9,750 | Yes | Form 4 |
| Smith Ian F | Oct 2 | Oct 6 | M | 3,440 | not reported | not reported | 141,585 | No | Form 4 |
| Smith Ian F | Oct 2 | Oct 6 | M · derivative | 3,440 | $0.00 | $0 | 3,440 | No | Form 4 |
| Smith Ian F | Jul 2 | Jul 7 | M | 3,440 | not reported | not reported | 138,145 | No | Form 4 |
| Smith Ian F | Jul 2 | Jul 7 | M · derivative | 3,440 | $0.00 | $0 | 6,880 | No | Form 4 |
| Stone Adam Leo | Jun 10 | Jun 11 | A · derivative | 77,500 | $6.61 | $512,275 | 77,500 | No | Form 4 |
| Sullivan Lynne Marie | Jun 10 | Jun 11 | A · derivative | 77,500 | $6.61 | $512,275 | 77,500 | No | Form 4 |
| Kahn Clare | Jun 10 | Jun 11 | A · derivative | 77,500 | $6.61 | $512,275 | 77,500 | No | Form 4 |
| Freed Martin I | Jun 10 | Jun 11 | A · derivative | 77,500 | $6.61 | $512,275 | 77,500 | No | Form 4 |
| Keresty Georgia | Jun 10 | Jun 11 | A · derivative | 77,500 | $6.61 | $512,275 | 77,500 | No | Form 4 |
| Edelman Joseph | Jun 10 | Jun 11 | A · derivative | 77,500 | $6.61 | $512,275 | 77,500 | No | Form 4 |
| Ganot Ilan | Jun 10 | Jun 11 | A · derivative | 77,500 | $6.61 | $512,275 | 77,500 | No | Form 4 |
| Smith Ian F | Jun 10 | Jun 11 | A · derivative | 77,500 | $6.61 | $512,275 | 77,500 | No | Form 4 |
| Nagendran Sukumar | Jun 10 | Jun 11 | A · derivative | 77,500 | $6.61 | $512,275 | 77,500 | No | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Jan 29 | Apr 21 | A · derivative | 54,925 | $0.00 | $0 | 54,925 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Jan 29 | Apr 21 | A · derivative | 56,647 | $0.00 | $0 | 56,647 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Jan 29 | Apr 21 | A · derivative | 54,925 | $0.00 | $0 | 54,925 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Jan 29 | Apr 21 | A · derivative | 58,847 | $0.00 | $0 | 58,847 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Jan 29 | Apr 21 | A · derivative | 169,401 | $0.00 | $0 | 169,401 | Yes | Form 4 |
| Howton David TChief Operating Officer | Jan 29 | Apr 21 | A · derivative | 79,341 | $0.00 | $0 | 79,341 | Yes | Form 4 |
| Smith Ian F | Apr 2 | Apr 2 | M | 3,441 | not reported | not reported | 134,705 | No | Form 4 |
| Smith Ian F | Apr 2 | Apr 2 | M · derivative | 3,441 | $0.00 | $0 | 10,320 | No | Form 4 |
| Perceptive Life Sciences Master Fund Ltd | Mar 9 | Mar 11 | A · derivative | 8,912,655 | $5.61 | $49,999,995 | 8,912,655 | No | Form 4 |
| Tan KevinCFO & Treasurer | Feb 18 | Feb 18 | S | 5,404 | $5.82 | Sale −$31,451 | 99,422 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Feb 18 | Feb 18 | S | 0 | $5.82 | Sale −$0 | 89,466 | Yes | Form 4 |
| Howton David TChief Operating Officer | Feb 18 | Feb 18 | S | 7,469 | $5.82 | Sale −$43,470 | 105,077 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Feb 18 | Feb 18 | S | 3,616 | $5.82 | Sale −$21,045 | 72,638 | Yes | Form 4 |
| Ganot Ilan | Feb 18 | Feb 18 | S | 2,658 | $5.82 | Sale −$15,470 | 27,474 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Feb 18 | Feb 18 | S | 4,134 | $5.82 | Sale −$24,060 | 74,318 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Feb 18 | Feb 18 | S | 16,644 | $5.82 | Sale −$96,868 | 235,405 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Feb 13 | Feb 18 | M | 10,625 | not reported | not reported | 104,826 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Feb 13 | Feb 18 | M · derivative | 10,625 | $0.00 | $0 | 21,250 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Feb 13 | Feb 18 | M | 10,937 | not reported | not reported | 95,029 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Feb 13 | Feb 18 | M · derivative | 10,937 | $0.00 | $0 | 21,876 | Yes | Form 4 |
| Howton David TChief Operating Officer | Feb 13 | Feb 18 | M | 14,687 | not reported | not reported | 112,546 | Yes | Form 4 |
| Howton David TChief Operating Officer | Feb 13 | Feb 18 | M · derivative | 14,687 | $0.00 | $0 | 29,376 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Feb 13 | Feb 18 | M | 7,187 | not reported | not reported | 76,254 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Feb 13 | Feb 18 | M · derivative | 7,187 | $0.00 | $0 | 14,376 | Yes | Form 4 |
| Ganot Ilan | Feb 13 | Feb 18 | M | 4,861 | not reported | not reported | 30,132 | Yes | Form 4 |
| Ganot Ilan | Feb 13 | Feb 18 | M · derivative | 4,861 | $0.00 | $0 | 9,722 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Feb 13 | Feb 18 | M | 8,125 | not reported | not reported | 78,452 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Feb 13 | Feb 18 | M · derivative | 8,125 | $0.00 | $0 | 16,250 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Feb 13 | Feb 18 | M | 30,031 | not reported | not reported | 252,049 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Feb 13 | Feb 18 | M · derivative | 30,031 | $0.00 | $0 | 60,063 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Feb 4 | Feb 6 | S | 10,905 | $6.44 | Sale −$70,228 | 69,067 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Feb 4 | Feb 6 | S | 12,348 | $6.44 | Sale −$79,521 | 70,327 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Feb 4 | Feb 6 | S | 12,616 | $6.44 | Sale −$81,247 | 84,092 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Feb 4 | Feb 6 | S | 14,783 | $6.44 | Sale −$95,203 | 94,201 | Yes | Form 4 |
| Ganot Ilan | Feb 4 | Feb 6 | S | 7,205 | $6.44 | Sale −$46,400 | 25,271 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Feb 4 | Feb 6 | S | 48,913 | $6.44 | Sale −$315,000 | 222,018 | Yes | Form 4 |
| Howton David TChief Operating Officer | Feb 4 | Feb 6 | S | 18,894 | $6.44 | Sale −$121,677 | 97,859 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Feb 2 | Feb 2 | S | 26,250 | $6.44 | Sale −$169,050 | 79,972 | Yes | Form 4 |
| Howton David TChief Operating Officer | Feb 2 | Feb 2 | S | 37,771 | $6.44 | Sale −$243,245 | 116,753 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Feb 2 | Feb 2 | S | 28,335 | $6.44 | Sale −$182,477 | 96,708 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Feb 2 | Feb 2 | S | 26,535 | $6.44 | Sale −$170,885 | 82,675 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Feb 2 | Feb 2 | S | 80,258 | $6.44 | Sale −$516,862 | 270,931 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Feb 2 | Feb 2 | S | 26,837 | $6.44 | Sale −$172,830 | 108,984 | Yes | Form 4 |
| Ganot Ilan | Jan 31 | Feb 2 | M | 15,000 | not reported | not reported | 32,476 | Yes | Form 4 |
| Ganot Ilan | Jan 31 | Feb 2 | M · derivative | 15,000 | $0.00 | $0 | 45,000 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Jan 31 | Feb 2 | M | 24,675 | not reported | not reported | 106,222 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Jan 31 | Feb 2 | M · derivative | 24,675 | $0.00 | $0 | 74,025 | Yes | Form 4 |
| Howton David TChief Operating Officer | Jan 31 | Feb 2 | M | 42,275 | not reported | not reported | 154,254 | Yes | Form 4 |
| Howton David TChief Operating Officer | Jan 31 | Feb 2 | M · derivative | 42,275 | $0.00 | $0 | 126,825 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Jan 31 | Feb 2 | M | 28,225 | not reported | not reported | 125,043 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Jan 31 | Feb 2 | M · derivative | 28,225 | $0.00 | $0 | 84,675 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Jan 31 | Feb 2 | M | 27,625 | not reported | not reported | 109,210 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Jan 31 | Feb 2 | M · derivative | 27,625 | $0.00 | $0 | 82,875 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Jan 31 | Feb 2 | M | 100,400 | not reported | not reported | 351,189 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Jan 31 | Feb 2 | M · derivative | 100,400 | $0.00 | $0 | 301,200 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Jan 31 | Feb 2 | M | 33,075 | not reported | not reported | 135,821 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Jan 31 | Feb 2 | M · derivative | 33,075 | $0.00 | $0 | 99,225 | Yes | Form 4 |
| Ganot Ilan | Jan 29 | Feb 2 | A · derivative | 70,900 | $6.60 | $467,940 | 70,900 | Yes | Form 4 |
| Ganot Ilan | Jan 29 | Feb 2 | A · derivative | 35,450 | $0.00 | $0 | 35,450 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Jan 29 | Feb 2 | M | 54,925 | not reported | not reported | 81,547 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Jan 29 | Feb 2 | M · derivative | 54,925 | $0.00 | $0 | not reported | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Jan 29 | Feb 2 | A · derivative | 170,000 | $6.60 | $1,122,000 | 170,000 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Jan 29 | Feb 2 | A · derivative | 85,000 | $0.00 | $0 | 85,000 | Yes | Form 4 |
| Howton David TChief Operating Officer | Jan 29 | Feb 2 | M | 79,341 | not reported | not reported | 112,249 | Yes | Form 4 |
| Howton David TChief Operating Officer | Jan 29 | Feb 2 | M · derivative | 79,341 | $0.00 | $0 | not reported | Yes | Form 4 |
| Howton David TChief Operating Officer | Jan 29 | Feb 2 | A · derivative | 210,200 | $6.60 | $1,387,320 | 210,200 | Yes | Form 4 |
| Howton David TChief Operating Officer | Jan 29 | Feb 2 | A · derivative | 105,100 | $0.00 | $0 | 105,100 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Jan 29 | Feb 2 | M | 58,847 | not reported | not reported | 96,818 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Jan 29 | Feb 2 | M · derivative | 58,847 | $0.00 | $0 | not reported | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Jan 29 | Feb 2 | A · derivative | 207,450 | $6.60 | $1,369,170 | 207,450 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Jan 29 | Feb 2 | A · derivative | 103,750 | $0.00 | $0 | 103,750 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Jan 29 | Feb 2 | M | 54,925 | not reported | not reported | 81,585 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Jan 29 | Feb 2 | M · derivative | 54,925 | $0.00 | $0 | not reported | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Jan 29 | Feb 2 | A · derivative | 190,000 | $6.60 | $1,254,000 | 190,000 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Jan 29 | Feb 2 | A · derivative | 95,000 | $0.00 | $0 | 95,000 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Jan 29 | Feb 2 | M | 169,401 | not reported | not reported | 250,789 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Jan 29 | Feb 2 | M · derivative | 169,401 | $0.00 | $0 | not reported | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Jan 29 | Feb 2 | A · derivative | 509,850 | $6.60 | $3,365,010 | 509,850 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Jan 29 | Feb 2 | A · derivative | 254,900 | $0.00 | $0 | 254,900 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Jan 29 | Feb 2 | M | 56,646 | not reported | not reported | 102,746 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Jan 29 | Feb 2 | M · derivative | 56,646 | $0.00 | $0 | not reported | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Jan 29 | Feb 2 | A · derivative | 187,000 | $6.60 | $1,234,200 | 187,000 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Jan 29 | Feb 2 | A · derivative | 93,500 | $0.00 | $0 | 93,500 | Yes | Form 4 |
| Ganot Ilan | Jan 28 | Jan 30 | S | 191 | $6.59 | Sale −$1,259 | 17,476 | Yes | Form 4 |
| Ganot Ilan | Jan 27 | Jan 30 | M | 389 | not reported | not reported | 17,667 | Yes | Form 4 |
| Ganot Ilan | Jan 27 | Jan 30 | M | 3,884 | not reported | not reported | 99,297 | Yes | Form 4 |
| Ganot Ilan | Jan 27 | Jan 30 | M · derivative | 389 | $0.00 | $0 | not reported | Yes | Form 4 |
| Ganot Ilan | Jan 27 | Jan 30 | M · derivative | 3,884 | $0.00 | $0 | not reported | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Jan 13 | Jan 13 | S | 5,704 | $5.27 | Sale −$30,060 | 46,100 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Jan 9 | Jan 13 | M | 11,250 | not reported | not reported | 51,804 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Jan 9 | Jan 13 | M · derivative | 11,250 | $0.00 | $0 | 11,250 | Yes | Form 4 |
| Smith Ian F | Jan 6 | Jan 7 | M | 4,573 | not reported | not reported | 131,264 | No | Form 4 |
| Smith Ian F | Jan 6 | Jan 7 | M · derivative | 4,573 | $0.00 | $0 | not reported | No | Form 4 |
| Smith Ian F | Jan 2 | Jan 7 | A · derivative | 18,012 | $5.45 | $98,165 | 18,012 | No | Form 4 |
| Smith Ian F | Jan 2 | Jan 7 | A · derivative | 13,761 | $0.00 | $0 | 13,761 | No | Form 4 |
| Ganot Ilan | Jan 5 | Jan 6 | S | 1,053 | $5.43 | Sale −$5,718 | 17,278 | No | Form 4 |
| Ganot Ilan | Jan 3 | Jan 6 | M | 2,994 | not reported | not reported | 18,331 | No | Form 4 |
| Ganot Ilan | Jan 3 | Jan 6 | M · derivative | 2,994 | $0.00 | $0 | 2,994 | No | Form 4 |
| Herzich PaulChief Technology Officer | Dec 3, 2025 | Dec 4, 2025 | S | 2,701 | $5.11 | Sale −$13,802 | 26,622 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Dec 3, 2025 | Dec 4, 2025 | S | 4,483 | $5.11 | Sale −$22,908 | 26,660 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Dec 3, 2025 | Dec 4, 2025 | S | 10,808 | $5.11 | Sale −$55,229 | 81,388 | Yes | Form 4 |
| Howton David TChief Operating Officer | Dec 3, 2025 | Dec 4, 2025 | S | 4,932 | $5.11 | Sale −$25,203 | 32,908 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Dec 2, 2025 | Dec 4, 2025 | M | 7,239 | not reported | not reported | 29,323 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Dec 2, 2025 | Dec 4, 2025 | M · derivative | 7,239 | $0.00 | $0 | 7,239 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Dec 2, 2025 | Dec 4, 2025 | M | 11,862 | not reported | not reported | 31,143 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Dec 2, 2025 | Dec 4, 2025 | M · derivative | 11,862 | $0.00 | $0 | 11,863 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Dec 2, 2025 | Dec 4, 2025 | M | 28,612 | not reported | not reported | 92,196 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Dec 2, 2025 | Dec 4, 2025 | M · derivative | 28,612 | $0.00 | $0 | 28,613 | Yes | Form 4 |
| Howton David TChief Operating Officer | Dec 2, 2025 | Dec 4, 2025 | M | 13,051 | not reported | not reported | 37,840 | Yes | Form 4 |
| Howton David TChief Operating Officer | Dec 2, 2025 | Dec 4, 2025 | M · derivative | 13,051 | $0.00 | $0 | 13,052 | Yes | Form 4 |
| Ganot Ilan | Nov 10, 2025 | Nov 13, 2025 | S | 3,278 | $4.12 | Sale −$13,505 | 95,412 | No | Form 4 |
| Brooks GabrielChief Medical Officer | Oct 20, 2025 | Oct 21, 2025 | S | 2,895 | $5.96 | Sale −$17,254 | 33,819 | No | Form 4 |
| Brooks GabrielChief Medical Officer | Oct 18, 2025 | Oct 21, 2025 | M | 9,750 | not reported | not reported | 36,714 | No | Form 4 |
| Brooks GabrielChief Medical Officer | Oct 18, 2025 | Oct 21, 2025 | M · derivative | 9,750 | $0.00 | $0 | 19,500 | No | Form 4 |
| Smith Ian F | Oct 6, 2025 | Oct 7, 2025 | M | 4,573 | not reported | not reported | 126,692 | No | Form 4 |
| Smith Ian F | Oct 6, 2025 | Oct 7, 2025 | M · derivative | 4,573 | $0.00 | $0 | 4,573 | No | Form 4 |
| Cumbo AlexanderPresident and CEO | Aug 14, 2025 | Aug 18, 2025 | A · derivative | 337,500 | $6.17 | $2,082,375 | 337,500 | No | Form 4 |
| Cumbo AlexanderPresident and CEO | Aug 14, 2025 | Aug 18, 2025 | A · derivative | 168,750 | $0.00 | $0 | 168,750 | No | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Aug 14, 2025 | Aug 18, 2025 | A · derivative | 142,500 | $6.17 | $879,225 | 142,500 | No | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Aug 14, 2025 | Aug 18, 2025 | A · derivative | 71,250 | $0.00 | $0 | 71,250 | No | Form 4 |
| Brooks GabrielChief Medical Officer | Aug 14, 2025 | Aug 18, 2025 | A · derivative | 142,500 | $6.17 | $879,225 | 142,500 | No | Form 4 |
| Brooks GabrielChief Medical Officer | Aug 14, 2025 | Aug 18, 2025 | A · derivative | 71,250 | $0.00 | $0 | 71,250 | No | Form 4 |
| Herzich PaulChief Technology Officer | Aug 14, 2025 | Aug 18, 2025 | A · derivative | 100,000 | $6.17 | $617,000 | 100,000 | No | Form 4 |
| Herzich PaulChief Technology Officer | Aug 14, 2025 | Aug 18, 2025 | A · derivative | 50,000 | $0.00 | $0 | 50,000 | No | Form 4 |
| Tan KevinCFO & Treasurer | Aug 14, 2025 | Aug 18, 2025 | A · derivative | 125,000 | $6.17 | $771,250 | 125,000 | No | Form 4 |
| Tan KevinCFO & Treasurer | Aug 14, 2025 | Aug 18, 2025 | A · derivative | 62,500 | $0.00 | $0 | 62,500 | No | Form 4 |
| Howton David TChief Operating Officer | Aug 14, 2025 | Aug 18, 2025 | A · derivative | 150,000 | $6.17 | $925,500 | 150,000 | No | Form 4 |
| Howton David TChief Operating Officer | Aug 14, 2025 | Aug 18, 2025 | A · derivative | 75,000 | $0.00 | $0 | 75,000 | No | Form 4 |
| Ganot Ilan | Aug 14, 2025 | Aug 18, 2025 | A · derivative | 37,500 | $6.17 | $231,375 | 37,500 | No | Form 4 |
| Ganot Ilan | Aug 14, 2025 | Aug 18, 2025 | A · derivative | 18,750 | $0.00 | $0 | 18,750 | No | Form 4 |
| Smith Ian F | Jul 6, 2025 | Jul 8, 2025 | M | 4,573 | not reported | not reported | 122,119 | No | Form 4 |
| Smith Ian F | Jul 6, 2025 | Jul 8, 2025 | M · derivative | 4,573 | $0.00 | $0 | 9,146 | No | Form 4 |
| Keresty Georgia | Jun 12, 2025 | Jun 18, 2025 | A · derivative | 77,500 | $4.58 | $354,950 | 77,500 | No | Form 4 |
| Sullivan Lynne Marie | Jun 12, 2025 | Jun 13, 2025 | A · derivative | 77,500 | $4.58 | $354,950 | 77,500 | No | Form 4 |
| Ganot Ilan | Jun 12, 2025 | Jun 13, 2025 | A · derivative | 77,500 | $4.58 | $354,950 | 77,500 | No | Form 4 |
| Kahn Clare | Jun 12, 2025 | Jun 13, 2025 | A · derivative | 77,500 | $4.58 | $354,950 | 77,500 | No | Form 4 |
| Nagendran Sukumar | Jun 12, 2025 | Jun 13, 2025 | A · derivative | 77,500 | $4.58 | $354,950 | 77,500 | No | Form 4 |
| Freed Martin I | Jun 12, 2025 | Jun 13, 2025 | A · derivative | 77,500 | $4.58 | $354,950 | 77,500 | No | Form 4 |
| Smith Ian F | Jun 12, 2025 | Jun 13, 2025 | A · derivative | 77,500 | $4.58 | $354,950 | 77,500 | No | Form 4 |
| Edelman Joseph | Jun 12, 2025 | Jun 13, 2025 | A · derivative | 77,500 | $4.58 | $354,950 | 77,500 | No | Form 4 |
| Stone Adam Leo | Jun 12, 2025 | Jun 13, 2025 | A · derivative | 77,500 | $4.58 | $354,950 | 77,500 | No | Form 4 |
| Smith Ian F | Apr 6, 2025 | Apr 8, 2025 | M | 4,574 | not reported | not reported | 117,546 | No | Form 4 |
| Smith Ian F | Apr 6, 2025 | Apr 8, 2025 | M · derivative | 4,574 | $0.00 | $0 | 13,719 | No | Form 4 |
| Kahn Clare | Mar 11, 2025 | Mar 13, 2025 | P | 1,860 | $5.34 | Purchase +$9,932 | 2,960 | No | Form 4 |
| BCLS SB Investco, LP | Feb 19, 2025 | Feb 21, 2025 | P | 1,000,000 | $4.03 | Purchase +$4,030,000 | 5,034,582 | No | Form 4 |
| BCLS SB Investco, LP | Feb 19, 2025 | Feb 21, 2025 | P · derivative | 6,444,170 | $4.03 | Purchase +$25,970,005 | 6,444,170 | No | Form 4 |
| Edelman Joseph | Feb 19, 2025 | Feb 21, 2025 | P | 5,000,000 | $4.03 | Purchase +$20,150,000 | 11,833,539 | No | Form 4 |
| Kolchinsky Peter | Feb 19, 2025 | Feb 21, 2025 | P · derivative | 3,722,085 | $4.03 | Purchase +$15,000,003 | 3,722,085 | No | Form 4 |
| Atchinson Robert | Feb 18, 2025 | Feb 19, 2025 | P | 252,545 | $7.56 | Purchase +$1,909,240 | 4,248,084 | No | Form 4 |
| Howton David TChief Operating Officer | Feb 14, 2025 | Feb 18, 2025 | S | 5,561 | $3.96 | Sale −$22,022 | 24,789 | Yes | Form 4 |
| Ganot Ilan | Feb 14, 2025 | Feb 18, 2025 | S | 1,711 | $3.96 | Sale −$6,776 | 14,839 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Feb 14, 2025 | Feb 18, 2025 | S | 11,365 | $3.96 | Sale −$45,005 | 60,717 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Feb 14, 2025 | Feb 18, 2025 | S | 2,688 | $3.96 | Sale −$10,644 | 18,388 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Feb 14, 2025 | Feb 18, 2025 | S | 3,164 | $3.96 | Sale −$12,529 | 32,250 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Feb 14, 2025 | Feb 18, 2025 | S | 3,256 | $3.96 | Sale −$12,894 | 22,812 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Feb 14, 2025 | Feb 18, 2025 | S | 3,079 | $3.96 | Sale −$12,193 | 19,281 | Yes | Form 4 |
| Howton David TChief Operating Officer | Feb 13, 2025 | Feb 18, 2025 | M | 14,687 | not reported | not reported | 30,350 | Yes | Form 4 |
| Howton David TChief Operating Officer | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 14,687 | $0.00 | $0 | 44,063 | Yes | Form 4 |
| Ganot Ilan | Feb 13, 2025 | Feb 18, 2025 | M | 4,861 | not reported | not reported | 16,550 | Yes | Form 4 |
| Ganot Ilan | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 4,861 | $0.00 | $0 | 14,583 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Feb 13, 2025 | Feb 18, 2025 | M | 30,031 | not reported | not reported | 72,082 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 30,031 | $0.00 | $0 | 90,094 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Feb 13, 2025 | Feb 18, 2025 | M | 7,187 | not reported | not reported | 21,076 | Yes | Form 4 |
| Herzich PaulChief Technology Officer | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 7,187 | $0.00 | $0 | 21,563 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Feb 13, 2025 | Feb 18, 2025 | M | 10,625 | not reported | not reported | 35,414 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 10,625 | $0.00 | $0 | 31,875 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Feb 13, 2025 | Feb 18, 2025 | M | 10,937 | not reported | not reported | 26,068 | Yes | Form 4 |
| Brooks GabrielChief Medical Officer | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 10,937 | $0.00 | $0 | 32,813 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Feb 13, 2025 | Feb 18, 2025 | M | 8,125 | not reported | not reported | 22,360 | Yes | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Feb 13, 2025 | Feb 18, 2025 | M · derivative | 8,125 | $0.00 | $0 | 24,375 | Yes | Form 4 |
| Cumbo AlexanderPresident and CEO | Jan 31, 2025 | Feb 11, 2025 | A · derivative | 401,600 | $0.00 | $0 | 401,600 | No | Form 4 |
| Howton David TChief Operating Officer | Jan 31, 2025 | Feb 11, 2025 | A · derivative | 169,100 | $0.00 | $0 | 169,100 | No | Form 4 |
| Brooks GabrielChief Medical Officer | Jan 31, 2025 | Feb 11, 2025 | A · derivative | 112,900 | $0.00 | $0 | 112,900 | No | Form 4 |
| Tan KevinCFO & Treasurer | Jan 31, 2025 | Feb 11, 2025 | A · derivative | 132,300 | $0.00 | $0 | 132,300 | No | Form 4 |
| Ganot Ilan | Jan 31, 2025 | Feb 11, 2025 | A · derivative | 60,000 | $0.00 | $0 | 60,000 | No | Form 4 |
| Herzich PaulChief Technology Officer | Jan 31, 2025 | Feb 11, 2025 | A · derivative | 98,700 | $0.00 | $0 | 98,700 | No | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Jan 31, 2025 | Feb 11, 2025 | A · derivative | 110,500 | $0.00 | $0 | 110,500 | No | Form 4 |
| Ganot Ilan | Jan 28, 2025 | Jan 29, 2025 | S | 144 | $3.11 | Sale −$448 | 11,689 | Yes | Form 4 |
| Ganot Ilan | Jan 27, 2025 | Jan 29, 2025 | M | 388 | not reported | not reported | 11,833 | Yes | Form 4 |
| Ganot Ilan | Jan 27, 2025 | Jan 29, 2025 | M | 3,883 | not reported | not reported | 98,690 | Yes | Form 4 |
| Ganot Ilan | Jan 27, 2025 | Jan 29, 2025 | M · derivative | 388 | $0.00 | $0 | 389 | Yes | Form 4 |
| Ganot Ilan | Jan 27, 2025 | Jan 29, 2025 | M · derivative | 3,883 | $0.00 | $0 | 3,884 | Yes | Form 4 |
| Tan KevinCFO & Treasurer | Jan 10, 2025 | Jan 13, 2025 | S | 4,073 | $3.89 | Sale −$15,844 | 24,789 | No | Form 4 |
| Tan KevinCFO & Treasurer | Jan 9, 2025 | Jan 13, 2025 | M | 11,250 | not reported | not reported | 28,862 | No | Form 4 |
| Tan KevinCFO & Treasurer | Jan 9, 2025 | Jan 13, 2025 | M · derivative | 11,250 | $0.00 | $0 | 22,500 | No | Form 4 |
| Smith Ian F | Jan 6, 2025 | Jan 7, 2025 | A · derivative | 22,148 | $4.10 | $90,807 | 22,148 | No | Form 4 |
| Smith Ian F | Jan 6, 2025 | Jan 7, 2025 | A · derivative | 18,293 | $0.00 | $0 | 18,293 | No | Form 4 |
| Ganot Ilan | Jan 6, 2025 | Jan 7, 2025 | S | 1,056 | $4.31 | Sale −$4,551 | 11,445 | No | Form 4 |
| Smith Ian F | Jan 3, 2025 | Jan 7, 2025 | M | 3,255 | not reported | not reported | 112,972 | No | Form 4 |
| Smith Ian F | Jan 3, 2025 | Jan 7, 2025 | M · derivative | 3,255 | $0.00 | $0 | not reported | No | Form 4 |
| Ganot Ilan | Jan 3, 2025 | Jan 7, 2025 | M | 2,994 | not reported | not reported | 12,501 | No | Form 4 |
| Ganot Ilan | Jan 3, 2025 | Jan 7, 2025 | M · derivative | 2,994 | $0.00 | $0 | 5,988 | No | Form 4 |
| Herzich PaulChief Technology Officer | Dec 3, 2024 | Dec 4, 2024 | S | 2,777 | $5.60 | Sale −$15,551 | 12,182 | No | Form 4 |
| Howton David TChief Operating Officer | Dec 3, 2024 | Dec 4, 2024 | S | 5,072 | $5.60 | Sale −$28,403 | 15,663 | No | Form 4 |
| Cumbo AlexanderPresident and CEO | Dec 3, 2024 | Dec 4, 2024 | S | 11,114 | $5.60 | Sale −$62,238 | 38,484 | No | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Dec 3, 2024 | Dec 4, 2024 | S | 4,610 | $5.60 | Sale −$25,816 | 14,235 | No | Form 4 |
| Herzich PaulChief Technology Officer | Dec 2, 2024 | Dec 4, 2024 | M | 7,239 | not reported | not reported | 14,959 | No | Form 4 |
| Herzich PaulChief Technology Officer | Dec 2, 2024 | Dec 4, 2024 | M · derivative | 7,239 | $0.00 | $0 | 14,478 | No | Form 4 |
| Howton David TChief Operating Officer | Dec 2, 2024 | Dec 4, 2024 | M | 13,051 | not reported | not reported | 20,735 | No | Form 4 |
| Howton David TChief Operating Officer | Dec 2, 2024 | Dec 4, 2024 | M · derivative | 13,051 | $0.00 | $0 | 26,103 | No | Form 4 |
| Cumbo AlexanderPresident and CEO | Dec 2, 2024 | Dec 4, 2024 | M | 28,612 | not reported | not reported | 49,598 | No | Form 4 |
| Cumbo AlexanderPresident and CEO | Dec 2, 2024 | Dec 4, 2024 | M · derivative | 28,612 | $0.00 | $0 | 57,225 | No | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Dec 2, 2024 | Dec 4, 2024 | M | 11,862 | not reported | not reported | 18,845 | No | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Dec 2, 2024 | Dec 4, 2024 | M · derivative | 11,862 | $0.00 | $0 | 23,725 | No | Form 4 |
| Edelman Joseph | Jun 11, 2024 | Nov 19, 2024 | A · derivative | 34,400 | $7.51 | $258,344 | 34,400 | No | Form 4 |
| Stone Adam Leo | Jun 11, 2024 | Nov 19, 2024 | A · derivative | 34,400 | $7.51 | $258,344 | 34,400 | No | Form 4 |
| Brooks GabrielChief Medical Officer | Oct 21, 2024 | Oct 22, 2024 | S | 2,923 | $6.50 | Sale −$19,000 | 10,979 | No | Form 4 |
| Brooks GabrielChief Medical Officer | Oct 18, 2024 | Oct 22, 2024 | M | 9,750 | not reported | not reported | 13,902 | No | Form 4 |
| Brooks GabrielChief Medical Officer | Oct 18, 2024 | Oct 22, 2024 | M · derivative | 9,750 | $0.00 | $0 | 29,250 | No | Form 4 |
| Smith Ian F | Oct 3, 2024 | Oct 4, 2024 | M | 3,255 | not reported | not reported | 109,717 | No | Form 4 |
| Smith Ian F | Oct 3, 2024 | Oct 4, 2024 | M · derivative | 3,255 | $0.00 | $0 | 3,255 | No | Form 4 |
| Smith Ian F | Jul 3, 2024 | Jul 5, 2024 | M | 3,255 | not reported | not reported | 106,462 | No | Form 4 |
| Smith Ian F | Jul 3, 2024 | Jul 5, 2024 | M · derivative | 3,255 | $0.00 | $0 | 6,510 | No | Form 4 |
| Ganot Ilan | Jun 11, 2024 | Jun 13, 2024 | A · derivative | 34,400 | $7.51 | $258,344 | 34,400 | No | Form 4 |
| Kahn Clare | Jun 11, 2024 | Jun 13, 2024 | A · derivative | 34,400 | $7.51 | $258,344 | 34,400 | No | Form 4 |
| Nagendran Sukumar | Jun 11, 2024 | Jun 13, 2024 | A · derivative | 34,400 | $7.51 | $258,344 | 34,400 | No | Form 4 |
| Freed Martin I | Jun 11, 2024 | Jun 13, 2024 | A · derivative | 34,400 | $7.51 | $258,344 | 34,400 | No | Form 4 |
| Sullivan Lynne Marie | Jun 11, 2024 | Jun 13, 2024 | A · derivative | 34,400 | $7.51 | $258,344 | 34,400 | No | Form 4 |
| Smith Ian F | Jun 11, 2024 | Jun 13, 2024 | A · derivative | 34,400 | $7.51 | $258,344 | 34,400 | No | Form 4 |
| Keresty Georgia | Jun 11, 2024 | Jun 13, 2024 | A · derivative | 34,400 | $7.51 | $258,344 | 34,400 | No | Form 4 |
| Kahn Clare | Jun 7, 2024 | Jun 11, 2024 | P | 1,100 | $7.67 | Purchase +$8,437 | 1,100 | No | Form 4 |
| Ganot Ilan | May 2, 2024 | May 6, 2024 | M | 1,553 | not reported | not reported | 9,969 | No | Form 4 |
| Ganot Ilan | May 2, 2024 | May 6, 2024 | S | 462 | $10.33 | Sale −$4,772 | 9,507 | No | Form 4 |
| Ganot Ilan | May 2, 2024 | May 6, 2024 | M · derivative | 1,553 | $0.00 | $0 | not reported | No | Form 4 |
| Smith Ian F | Apr 3, 2024 | Apr 5, 2024 | M | 3,256 | not reported | not reported | 103,207 | No | Form 4 |
| Smith Ian F | Apr 3, 2024 | Apr 5, 2024 | M · derivative | 3,256 | $0.00 | $0 | 9,765 | No | Form 4 |
| Ganot Ilan | Feb 13, 2024 | Feb 16, 2024 | A · derivative | 19,444 | $0.00 | $0 | 19,444 | No | Form 4 |
| Herzich PaulChief Technology Officer | Feb 13, 2024 | Feb 16, 2024 | A · derivative | 57,500 | $7.85 | $451,375 | 57,500 | No | Form 4 |
| Herzich PaulChief Technology Officer | Feb 13, 2024 | Feb 16, 2024 | A · derivative | 28,750 | $0.00 | $0 | 28,750 | No | Form 4 |
| Marlowe JenniferCSO | Feb 13, 2024 | Feb 16, 2024 | A · derivative | 90,000 | $7.85 | $706,500 | 90,000 | No | Form 4 |
| Marlowe JenniferCSO | Feb 13, 2024 | Feb 16, 2024 | A · derivative | 45,000 | $0.00 | $0 | 45,000 | No | Form 4 |
| Howton David TChief Operating Officer | Feb 13, 2024 | Feb 16, 2024 | A · derivative | 117,500 | $7.85 | $922,375 | 117,500 | No | Form 4 |
| Howton David TChief Operating Officer | Feb 13, 2024 | Feb 16, 2024 | A · derivative | 58,750 | $0.00 | $0 | 58,750 | No | Form 4 |
| Tan KevinCFO & Treasurer | Feb 13, 2024 | Feb 16, 2024 | A · derivative | 85,000 | $7.85 | $667,250 | 85,000 | No | Form 4 |
| Tan KevinCFO & Treasurer | Feb 13, 2024 | Feb 16, 2024 | A · derivative | 42,500 | $0.00 | $0 | 42,500 | No | Form 4 |
| Brooks GabrielChief Medical Officer | Feb 13, 2024 | Feb 16, 2024 | A · derivative | 87,500 | $7.85 | $686,875 | 87,500 | No | Form 4 |
| Brooks GabrielChief Medical Officer | Feb 13, 2024 | Feb 16, 2024 | A · derivative | 43,750 | $0.00 | $0 | 43,750 | No | Form 4 |
| Cumbo AlexanderPresident and CEO | Feb 13, 2024 | Feb 16, 2024 | A · derivative | 240,250 | $7.85 | $1,885,963 | 240,250 | No | Form 4 |
| Cumbo AlexanderPresident and CEO | Feb 13, 2024 | Feb 16, 2024 | A · derivative | 120,125 | $0.00 | $0 | 120,125 | No | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Feb 13, 2024 | Feb 16, 2024 | A · derivative | 65,000 | $7.85 | $510,250 | 65,000 | No | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Feb 13, 2024 | Feb 16, 2024 | A · derivative | 32,500 | $0.00 | $0 | 32,500 | No | Form 4 |
| Ganot Ilan | Jan 29, 2024 | Jan 30, 2024 | S | 139 | $7.99 | Sale −$1,111 | 8,416 | No | Form 4 |
| Ganot Ilan | Jan 27, 2024 | Jan 30, 2024 | M | 388 | not reported | not reported | 8,555 | No | Form 4 |
| Ganot Ilan | Jan 27, 2024 | Jan 30, 2024 | M | 3,883 | not reported | not reported | 94,807 | No | Form 4 |
| Ganot Ilan | Jan 27, 2024 | Jan 30, 2024 | M · derivative | 388 | $0.00 | $0 | 777 | No | Form 4 |
| Ganot Ilan | Jan 27, 2024 | Jan 30, 2024 | M · derivative | 3,883 | $0.00 | $0 | 7,767 | No | Form 4 |
| Koppel Adam | Jan 11, 2024 | Jan 12, 2024 | A | 904,160 | $5.53 | $5,000,005 | 4,034,582 | No | Form 4 |
| BCLS SB Investco, LP | Jan 11, 2024 | Jan 12, 2024 | A | 904,160 | $5.53 | $5,000,005 | 4,034,582 | No | Form 4 |
| Perceptive Xontogeny Venture Fund, LP | Jan 11, 2024 | Jan 12, 2024 | P | 3,410,713 | $5.53 | Purchase +$18,861,243 | 6,833,539 | No | Form 4 |
| RA Capital Nexus Fund, L.P. | Jan 11, 2024 | Jan 12, 2024 | P | 904,160 | $5.53 | Purchase +$5,000,005 | 4,192,216 | No | Form 4 |
| Tan KevinCFO & Treasurer | Jan 9, 2024 | Jan 11, 2024 | M | 11,250 | not reported | not reported | 13,243 | No | Form 4 |
| Tan KevinCFO & Treasurer | Jan 9, 2024 | Jan 11, 2024 | S | 3,935 | $8.20 | Sale −$32,267 | 9,308 | No | Form 4 |
| Tan KevinCFO & Treasurer | Jan 9, 2024 | Jan 11, 2024 | M · derivative | 11,250 | $0.00 | $0 | 33,750 | No | Form 4 |
| Smith Ian F | Jan 3, 2024 | Jan 5, 2024 | M | 15,570 | not reported | not reported | 99,948 | No | Form 4 |
| Smith Ian F | Jan 3, 2024 | Jan 5, 2024 | M · derivative | 15,570 | $0.00 | $0 | not reported | No | Form 4 |
| Smith Ian F | Jan 3, 2024 | Jan 5, 2024 | A · derivative | 15,112 | $5.76 | $87,045 | 15,112 | No | Form 4 |
| Smith Ian F | Jan 3, 2024 | Jan 5, 2024 | A · derivative | 13,021 | $0.00 | $0 | 13,021 | No | Form 4 |
| Ganot Ilan | Jan 3, 2024 | Jan 5, 2024 | M | 2,993 | not reported | not reported | 9,309 | No | Form 4 |
| Ganot Ilan | Jan 3, 2024 | Jan 5, 2024 | S | 1,142 | $5.30 | Sale −$6,053 | 8,167 | No | Form 4 |
| Ganot Ilan | Jan 3, 2024 | Jan 5, 2024 | M · derivative | 2,993 | $0.00 | $0 | 8,982 | No | Form 4 |
| Marlowe JenniferCSO | Dec 4, 2023 | Dec 5, 2023 | S | 4,890 | $2.77 | Sale −$13,545 | 6,998 | No | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Dec 4, 2023 | Dec 5, 2023 | S | 4,879 | $2.78 | Sale −$13,564 | 6,983 | No | Form 4 |
| Herzich PaulChief Technology Officer | Dec 4, 2023 | Dec 5, 2023 | S | 2,968 | $2.77 | Sale −$8,221 | 4,270 | No | Form 4 |
| Howton David TChief Operating Officer | Dec 4, 2023 | Dec 5, 2023 | S | 5,367 | $2.78 | Sale −$14,920 | 7,684 | No | Form 4 |
| Cumbo AlexanderPresident and CEO | Dec 4, 2023 | Dec 5, 2023 | S | 11,757 | $2.77 | Sale −$32,567 | 17,439 | No | Form 4 |
| Marlowe JenniferCSO | Dec 2, 2023 | Dec 5, 2023 | M | 11,888 | not reported | not reported | 11,888 | No | Form 4 |
| Marlowe JenniferCSO | Dec 2, 2023 | Dec 5, 2023 | M · derivative | 11,888 | $0.00 | $0 | 35,667 | No | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Dec 2, 2023 | Dec 5, 2023 | M | 11,862 | not reported | not reported | 11,862 | No | Form 4 |
| Hanrahan JessieChief Regulatory Officer | Dec 2, 2023 | Dec 5, 2023 | M · derivative | 11,862 | $0.00 | $0 | 35,587 | No | Form 4 |
| Herzich PaulChief Technology Officer | Dec 2, 2023 | Dec 5, 2023 | M | 7,238 | not reported | not reported | 7,238 | No | Form 4 |
| Herzich PaulChief Technology Officer | Dec 2, 2023 | Dec 5, 2023 | M · derivative | 7,238 | $0.00 | $0 | 21,717 | No | Form 4 |
| Howton David TChief Operating Officer | Dec 2, 2023 | Dec 5, 2023 | M | 13,051 | not reported | not reported | 13,051 | No | Form 4 |
| Howton David TChief Operating Officer | Dec 2, 2023 | Dec 5, 2023 | M · derivative | 13,051 | $0.00 | $0 | 39,154 | No | Form 4 |
| Ganot Ilan | Dec 2, 2023 | Dec 5, 2023 | M | 1,583 | not reported | not reported | 90,924 | No | Form 4 |
| Ganot Ilan | Dec 2, 2023 | Dec 5, 2023 | M · derivative | 1,583 | $0.00 | $0 | not reported | No | Form 4 |
| Cumbo AlexanderPresident and CEO | Dec 2, 2023 | Dec 5, 2023 | M | 28,612 | not reported | not reported | 29,196 | No | Form 4 |
| Cumbo AlexanderPresident and CEO | Dec 2, 2023 | Dec 5, 2023 | M · derivative | 28,612 | $0.00 | $0 | 85,837 | No | Form 4 |
| Brooks GabrielChief Medical Officer | Oct 18, 2023 | Oct 20, 2023 | A · derivative | 78,000 | $2.15 | $167,700 | 78,000 | No | Form 4 |
| Brooks GabrielChief Medical Officer | Oct 18, 2023 | Oct 20, 2023 | A · derivative | 39,000 | $0.00 | $0 | 39,000 | No | Form 4 |
| Smith Ian F | Oct 3, 2023 | Oct 5, 2023 | M | 15,569 | not reported | not reported | 84,378 | No | Form 4 |
| Smith Ian F | Oct 3, 2023 | Oct 5, 2023 | M · derivative | 15,569 | $0.00 | $0 | 15,570 | No | Form 4 |